[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-369496-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-369496-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","pan-cancer-analysis-of-phagocytosis-regulators-in-female-specific-cancers-a-focus-on-hmgb2","Pan-cancer analysis of phagocytosis regulators in female-specific cancers: a focus on HMGB2","","Tumor-associated macrophages drive immune escape and cancer progression within the tumor microenvironment, making phagocytosis regulators a key target for female-specific cancers. The study integrates public databases to evaluate expression, somatic mutations, copy number variation, DNA methylation, pathways, survival associations, and drug sensitivity, and uses immune modulators, immune infiltration, and single-cell data to infer cellular origins. In vitro assays validate HMGB2’s functional role. HMGB2 knockdown suppresses proliferation, migration, invasion, and macrophage-mediated phagocytosis across multiple female cancers and enhances therapeutic impact with Palbociclib.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/pan-cancer-analysis-of-phagocytosis-regulators-in-female-specific-cancers-a-focus-on-hmgb2/369496/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/pan-cancer-analysis-of-phagocytosis-regulators-in-female-specific-cancers-a-focus-on-hmgb2/369496.png","ImageObject",300,407,{"name":42,"@type":43},"Aria Callaghan","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-17","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",7,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What is the study’s main focus regarding phagocytosis regulators?","Question",{"text":63,"@type":64},"The study examines phagocytosis regulators across female-specific cancers and highlights HMGB2 as a pivotal factor in tumor progression.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"Which data types and analyses are used to study phagocytosis regulators?",{"text":68,"@type":64},"Public databases are used to assess expression, somatic mutations, copy number variations, DNA methylation, biological pathways, survival outcomes, and drug sensitivity, alongside immune modulation and infiltration analyses and single-cell sequencing.",{"name":70,"@type":61,"acceptedAnswer":71},"What functional effects does HMGB2 knockdown produce?",{"text":72,"@type":64},"HMGB2 knockdown inhibits proliferation, migration, and invasion in female-specific cancers and impairs macrophage-mediated phagocytosis of breast, cervical, ovarian, and endometrial cancer cells.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},369496,1791085940,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":99,"preview_page_count":33,"preview_urls":145},962084926284,"https://ap-avatar.wpscdn.com/davatar_29158cc5080c5b710cf443261637dec0","TYPE Original Research PUBLISHED 06 May 2025  \nDOI 10.3389/fimmu.2025.1565924  \nOPEN ACCESS  \nEDITED BY  \nRuicai Gu,  \nUniversity of Oklahoma Health Sciences Center, United States  \nREVIEWED BY  \nJindong Xie,  \nSun Yat-sen University Cancer Center (SYSUCC), China  \nShushu Zhao,  \nWistar Institute, United States  \n*CORRESPONDENCE  \nXiaoqin Lu  \n [luxq1118@zzu.edu.cn](luxq1118@zzu.edu.cn)  \n†These authors have contributed equally to this work and share ﬁrst authorship  \nRECEIVED 23 January 2025  \nACCEPTED 09 April 2025  \nPUBLISHED 06 May 2025  \nCITATION  \nLu X, Ren D, Zhao P, Li Y, Wang Z and Zhang J (2025) Pan-cancer analysis of phagocytosis regulators in female-speciﬁc cancers: a focus on HMGB2 .  \nFront. Immunol. 16:1565924 .  \ndoi: 10.3389/fimmu.2025.1565924  \nCOPYRIGHT  \n© 2025 Lu, Ren, Zhao, Li, Wang and Zhang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY) . The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.  \nPan-cancer analysis of phagocytosis regulators in female-speciﬁc cancers:  \na focus on HMGB2  \nXiaoqin Lu*†, Dan Ren †, Panpan Zhao, Yanfang Li, Zhenhui Wang and Jingyan Zhang  \nDepartment of Obstetrics and Gynecology, The Second Afﬁliated Hospital of Zhengzhou University, Zhengzhou, Henan, China  \nIntroduction: Tumor-associated macrophages (TAMs) play a crucial role in the tumor microenvironment, regulating immune escape and promoting cancer progression. Understanding the role of phagocytosis regulators in femalespeciﬁc cancers is essential for developing effective therapeutic strategies.  \nMethods: We performed comprehensive analyses of public databases to evaluate the expression, somatic mutations, and copy number variations of phagocytosis regulators. DNA methylation patterns, biological pathways, survival outcomes, and drug sensitivity were assessed. Additionally, immune modulators, immune cell inﬁltration, and single-cell sequencing were used to explore alterations in phagocytosis and their cellular origins. The functional role of HMGB2 in tumor cell behavior was validated through in vitro assays.  \nResults: Phagocytosis regulators exhibited differential expression across various female-speciﬁc cancers, with key genes such as CD47 and FOXO1 playing signiﬁcant roles in modulating tumor progression. High-frequency mutations were found in PTEN, ARID1A, and UBR4 . Genes like COX5B and MS4A1 emerged as potential predictors of clinical outcomes and therapeutic response. HMGB2 knockdown signiﬁcantly inhibited cancer cell proliferation, migration, and invasion in female-speciﬁc cancers. HMGB2 knockdown in macrophages led to a signiﬁcant impairment in phagocytosis of breast, cervical, ovarian, and endometrial cancer cells . Furthermore, when HMGB2 knockdown was combined with Palbociclib treatment, a signiﬁcant decrease in tumor cell proliferation was observed across multiple cancer models.  \nConclusion: This study highlights the pivotal role of phagocytosis regulators, particularly HMGB2, in the progression of female-speciﬁc cancers. Targeting HMGB2 offers promising therapeutic opportunities, potentially enhancing precision oncology and improving patient outcomes.  \nKEYWORDS  \nphagocytosis regulators, HMGB2, female-speciﬁc cancers, tumor microenvironment, cancer proliferation and invasion, therapeutic targets  \nFrontiers in Immunology 01 [frontiersin.org](frontiersin.org)  \n1 Introduction  \nFemale-speciﬁc cancers, particularly breast, cervical, ovarian, and endometrial cancers, collectively represent a critical health concern globally due to their high incidence and signiﬁcant impact on mortality rates. Breast cancer remains the most frequently diagnosed malignancy in women w","cbCaiu9rA2zmpcqv","https://ap.wps.com/l/cbCaiu9rA2zmpcqv","pdf",19212238,24,"English","# Introduction\n## Pan-cancer framework and immune escape\n# Methods\n## Multi-omics analyses and immune profiling\n## Functional validation of HMGB2\n# Results\n## Differential expression and mutation landscape\n## HMGB2 knockdown effects and therapeutic synergy\n# Conclusion","[{\"question\":\"What is the study’s main focus regarding phagocytosis regulators?\",\"answer\":\"The study examines phagocytosis regulators across female-specific cancers and highlights HMGB2 as a pivotal factor in tumor progression.\"},{\"question\":\"Which data types and analyses are used to study phagocytosis regulators?\",\"answer\":\"Public databases are used to assess expression, somatic mutations, copy number variations, DNA methylation, biological pathways, survival outcomes, and drug sensitivity, alongside immune modulation and infiltration analyses and single-cell sequencing.\"},{\"question\":\"What functional effects does HMGB2 knockdown produce?\",\"answer\":\"HMGB2 knockdown inhibits proliferation, migration, and invasion in female-specific cancers and impairs macrophage-mediated phagocytosis of breast, cervical, ovarian, and endometrial cancer cells.\"}]","Pan-cancer analysis of phagocytosis regulators in female-specific cancers: a focus on HMGB2 | PDF",1790183074,[146,150,154,158],{"page_no":22,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/923a942177c0bf9d3f07c8e644979b95.webp",983,1389,{"page_no":26,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/abd09dfdc89ee43f3337e17539aeedcf.webp",982,1388,{"page_no":30,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7098c3d2cf1f7d70d175d790486782bf.webp",981,1386,{"page_no":33,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5b192dcc559a436031f658ecefa35f34.webp",980,1385]